EDSA
Edesa Biotech, Inc.NASDAQHealthcare$6.14-5.21%ClosedMarket Cap: $51.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.33
P/S
0.00
EV/EBITDA
-4.70
DCF Value
$1.83
FCF Yield
-16.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-55.8%
ROA
-53.1%
ROIC
-59.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $0.00 | -Infinity% | $-2.3M | $-2.2M | $-0.28 | — |
| Q4 2025 | $0.00 | -Infinity% | $-2.5M | $-2.2M | $-0.32 | — |
| FY 2025 | $0.00 | -Infinity% | $-7.9M | $-7.2M | $-1.27 | — |
| Q3 2025 | $0.00 | -Infinity% | $-1.9M | $-1.7M | $-0.25 | — |
| Q2 2025 | $0.00 | -Infinity% | $-1.6M | $-1.6M | $-0.30 | — |
| Q1 2025 | $0.00 | -Infinity% | $-1.9M | $-1.6M | $-0.48 | — |
| Q4 2024 | $0.00 | NaN% | $-1.0M | $-962.1K | $-0.30 | — |
| FY 2024 | $0.00 | -Infinity% | $-7.0M | $-6.2M | $-1.93 | — |
| Q3 2024 | $0.00 | -Infinity% | $-1.9M | $-1.7M | $-0.52 | — |
| Q2 2024 | $0.00 | -Infinity% | $-2.2M | $-1.9M | $-0.58 | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.9M | $-1.7M | $-0.54 | — |
| Q4 2023 | $-1.1M | 104.1% | $-2.4M | $-1.7M | $-0.57 | — |